Rong Yan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rong Yan has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Bocheng Xu
MOE Key Laboratory of Macromolecule Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, PR China
1 shared publication - Chen Yang
Center for Drug Safety Evaluation and Research, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310007, China
1 shared publication - Fengqin Wang1 shared publication
Haiqiao He
1 shared publicationHuiQun ZHANG
Key Laboratory of Resources Biology and Biotechnology in Western China, Ministry of Education, Faculty of Life Sciences, Northwest University, Xi'an 710069, China
1 shared publicationHuiju Chen
1 shared publication
Latest Publications
- Open Access
- 27 March 2026
- Published by Elsevier in Journal of Applied Poultry Research
- Vol. 35 (3)
Effects of Chinese herbal extract D against Escherchia coli and on production performance and gut health in White Carneau squabs
- 27 March 2026
- Published by Elsevier in Journal of Applied Poultry Research
- Vol. 35 (3)
Open AccessEffects of Chinese herbal extract D against Escherchia coli and on production performance and gut health in White Carneau squabs
- Open Access
- 27 June 2024
- Published by Elsevier in Journal of Functional Foods
- Vol. 119
Protective effects of Bacillus amyloliquefaciens-derived nonapeptide in cyclophosphamide-induced immunosuppressed mice
- 27 June 2024
- Published by Elsevier in Journal of Functional Foods
- Vol. 119
Open AccessProtective effects of Bacillus amyloliquefaciens-derived nonapeptide in cyclophosphamide-induced immunosuppressed mice
- Open Access
- 29 September 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (39) , eadf8782
Gut-targeted nanoparticles deliver specifically targeted antimicrobial peptides against Clostridium perfringens infections
Specifically targeted antimicrobial peptides (STAMPs) are novel alternatives to antibiotics, whereas the development of STAMPs for colonic infections is hindered by limited de novo design efficiency and colonic bioavailability. In this study, we report an efficient de novo STAMP design strategy that combines a traversal design, machine learning model, and phage display technology to identify STAMPs against Clostridium perfringens . STAMPs could physically damage C. perfringens , eliminate biofilms, and self-assemble into nanoparticles to entrap pathogens. Further, a gut-targeted engineering particle vaccine (EPV) was used for STAMPs delivery. In vivo studies showed that both STAMP and EPV@STAMP effectively limited C. perfringens infections and then reduced inflammatory response. Notably, EPV@STAMP exhibited stronger protection against colonic infections than STAMPs alone. Moreover, 16 S ribosomal RNA sequencing showed that both STAMPs and EPV@STAMP facilitated the recovery of disturbed gut microflora. Collectively, our work may accelerate the development of the discovery and delivery of precise antimicrobials.
- 29 September 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (39) , eadf8782
Open AccessGut-targeted nanoparticles deliver specifically targeted antimicrobial peptides against Clostridium perfringens infections
Specifically targeted antimicrobial peptides (STAMPs) are novel alternatives to antibiotics, whereas the development of STAMPs for colonic infections is hindered by limited de novo design efficiency and colonic bioavailability. In this study, we report an efficient de novo STAMP design strategy that combines a traversal design, machine learning model, and phage display technology to identify STAMPs against Clostridium perfringens . STAMPs could physically damage C. perfringens , eliminate biofilms, and self-assemble into nanoparticles to entrap pathogens. Further, a gut-targeted engineering particle vaccine (EPV) was used for STAMPs delivery. In vivo studies showed that both STAMP and EPV@STAMP effectively limited C. perfringens infections and then reduced inflammatory response. Notably, EPV@STAMP exhibited stronger protection against colonic infections than STAMPs alone. Moreover, 16 S ribosomal RNA sequencing showed that both STAMPs and EPV@STAMP facilitated the recovery of disturbed gut microflora. Collectively, our work may accelerate the development of the discovery and delivery of precise antimicrobials.
- Open Access
- 1 July 2016
- Published by Science China Press., Co. Ltd. in SCIENTIA SINICA Vitae
- Vol. 46 (7) , 861-871
Identification of Genes that Regulate rsmA and Phenotypes Affected
RsmA is a key post-translational regulator that controls multiple virulence factors in human pathogen Pseudomonas aeruginosa. In this study, we used an rsmA-luxCDABE reporter integrated on the chromosome of P. aeruginosa to identify genes that influence the expression of rsmA. We screened a transposon mutant library of 30,000 clones for mutants that exhibited either increased or decreased expression of rsmA. Of the total of 20 confirmed mutants, 14 demonstrated a reduced expression of rsmA and 6 increased expression. Seven genes disrupted by transposon insertion were eventually identified by arbitrary PCR and sequence alignment. In agreement with the important roles of RsmA, bacterial motility, pyocyanin and extracellular polysaccharide production were affected at various degrees in these mutants. Identification of these putative regulators of rsmA provides not only new information of the complex regulatory networks that govern the pathogenicity of P. aeruginosa, but also potential new targets for controlling P. aeruginosa virulence.
- 1 July 2016
- Published by Science China Press., Co. Ltd. in SCIENTIA SINICA Vitae
- Vol. 46 (7) , 861-871
Open AccessIdentification of Genes that Regulate rsmA and Phenotypes Affected
RsmA is a key post-translational regulator that controls multiple virulence factors in human pathogen Pseudomonas aeruginosa. In this study, we used an rsmA-luxCDABE reporter integrated on the chromosome of P. aeruginosa to identify genes that influence the expression of rsmA. We screened a transposon mutant library of 30,000 clones for mutants that exhibited either increased or decreased expression of rsmA. Of the total of 20 confirmed mutants, 14 demonstrated a reduced expression of rsmA and 6 increased expression. Seven genes disrupted by transposon insertion were eventually identified by arbitrary PCR and sequence alignment. In agreement with the important roles of RsmA, bacterial motility, pyocyanin and extracellular polysaccharide production were affected at various degrees in these mutants. Identification of these putative regulators of rsmA provides not only new information of the complex regulatory networks that govern the pathogenicity of P. aeruginosa, but also potential new targets for controlling P. aeruginosa virulence.